Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

TD Cowen Downgrades Thorne HealthTech to Market Perform, Raises Price Target to $10.2

Author: Benzinga Newsdesk | August 30, 2023 04:30am
TD Cowen analyst Oliver Chen downgrades Thorne HealthTech (NASDAQ:THRN) from Outperform to Market Perform and raises the price target from $8 to $10.2.

Posted In: THRN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist